Will a novel form of oral peanut immunotherapy induce regulatory immune responses and modify the gastrointestinal microbiome ?

Summary

In this part of the study, we will investigate the immunological mechanisms involved in the desensitization process. This will include the effects of short chained fatty acids in the T-regulatory cell compartment. We will apply functional as well as phenotypic analysis of ex-vivo derived T-cells and be linking these results with GUT microbiome data as well as with clinical outcomes.

Supervisor(s)

Professor Ralph Nanan

Research Location

Nepean - Nepean Clinical School

Program Type

Masters/PHD

Synopsis

Peanut allergy is common and there is no cure. Current studies of peanut immunotherapy have shown the effects are not generally long lasting. We plan to study a novel form of oral peanut immunotherapy using peanut and a dietary fibre (modified starch) supplement. We have evidence that the diet supplement protects animals from developing food allergy and that this form of supplement modulates important protective immune responses in human cells in the laboratory.

Additional Information

Funding: The candidate will be expected to obtain a post-graduate scholarship with assistance from this Supervisor when applying for this opportunity. See the Scholarships Office Website for further information. Additional part time employment opportunities within the Paediatric Immunology Laboratory concurrent to the PhD/Masters period is expected to be available.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Nepean - Nepean Clinical School .

Keywords

peanut allergy, immunotherapy, dietary fibre, desensitization, microbiome

Opportunity ID

The opportunity ID for this research opportunity is: 2636

Other opportunities with Professor Ralph Nanan